M21-1 and 38 CFR changes, week of Oct 17, 2022

Added

• Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count <500 × 109/L | 70

Removed

• Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count <500 × 10
• 9/L | 70

Added

• Minimum rating for through-and-through wounds of the foot—10.
• Slight | 0
• * If bilateral, see § 3.350(a)(3) of this chapter to determine whether the veteran may be entitled to special monthly compensation.

and 10 more added passages

Removed

• The Shoulder Girdle and Arm | Rating
• The Forearm and Hand | Rating
• The Foot and Leg | Rating
• Minimum rating for through-and-through wounds of the foot - 10.
• The Pelvic Girdle and Thigh | Rating
• Slight | 0* If bilateral, see § 3.350(a)(3) of this chapter to determine whether the veteran may be entitled to special monthly compensation.
• The Torso and Neck | Rating
• Miscellaneous | Rating

and 4 more removed passages

Added

• 6061 Anatomical loss of both eyes 1 | 100
• 6062 No more than light perception in both eyes 1 | 100
• In the other eye 5/200 (1.5/60) | 1 100
• Degree of diplopia | Equivalentvisual acuity

and 2 more added passages

Removed

• Diseases of the Eye | Rating
• 6061 Anatomical loss of both eyes
• 1 | 100
• 6062 No more than light perception in both eyes
• 1 | 100
• In the other eye 5/200 (1.5/60) | 1100
• Ratings for Impairment of Visual Fields | Rating
• Ratings for Impairment of Muscle FunctionDegree of diplopia | Equivalent

and 1 more removed passages